Oticon and Oticon Medical (collectively denoted OTIC), both part of William Demant Holding, are global companies in hearing instruments and implantable hearing solutions committed to developing bone conduction implant and cochlear implant device technology. As a member of one of the world’s largest groups of hearing health care companies, OTIC have direct access to the latest advancements in hearing research and technologies. OTIC employs more than 13000 people around the world and is represented in more than 100 countries. OTIC has extensive experience with stakeholder involvement and co-creation throughout the research and innovation lifecycle. OTIC frequently conducts observations, innovation focus and workshops, usability tests, field tests, etc. in an iterative process to ensure that all products and services innovated meet the needs and requirements of stakeholders, including people with hearing impairment.
The Eriksholm Research Centre, part of Oticon Medical, has an active present and history of research conducted in collaboration with academic institutions. Researchers from the Eriksholm Research Centre will be actively involved in the Comm4CHILD training network.